IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i5p2761-d759927.html
   My bibliography  Save this article

A Successful Outcome of Veno-Venous Extracorporeal Membrane Oxygenation in Obese Patients with Respiratory Failure in the Course of COVID-19: A Report of Two Cases

Author

Listed:
  • Jarosław Janc

    (Department of Anaesthesiology and Intensive Therapy, 4th Military Clinical Hospital, 50-981 Wroclaw, Poland)

  • Lidia Łysenko

    (Department of Anaesthesiology and Intensive Therapy, Wroclaw Medical University, 50-529 Wroclaw, Poland)

  • Olga Lewandowska

    (Department of Anaesthesiology and Intensive Therapy, 4th Military Clinical Hospital, 50-981 Wroclaw, Poland)

  • Olimpia Chrzan

    (Department of Anaesthesiology and Intensive Therapy, 4th Military Clinical Hospital, 50-981 Wroclaw, Poland)

  • Michał Suchański

    (Department of Anaesthesiology and Intensive Therapy, 4th Military Clinical Hospital, 50-981 Wroclaw, Poland)

  • Marek Gemel

    (Department of Cardiac Surgery, 4th Military Clinical Hospital, 50-981 Wroclaw, Poland)

  • Patrycja Leśnik

    (Department of Anaesthesiology and Intensive Therapy, 4th Military Clinical Hospital, 50-981 Wroclaw, Poland)

Abstract

The use of extracorporeal membrane oxygenation (ECMO) in patients with respiratory failure in the course of COVID-19 indicates its limited efficacy and high mortality rates. It seems that one of the conditions for the success of veno-venous ECMO (VV ECMO) in obese patients with COVID-19 is the correct qualification and rapid implementation of this method. We present two cases of obese patients with acute respiratory distress syndrome (ARDS) as a result of SARS-CoV-2 infection with the successful use of ECMO. Two 41-year-old obese patients (Case 1: BMI 31.5 kg/m 2 and Case 2: 44.5 kg/m 2 ), with pneumonia and severe respiratory failure in the course of COVID-19, underwent ECMO therapy. The Extracorporeal Life Support Organization (ELSO) guidelines were used to qualify the patients. Due to the persistence of PaO 2 /FiO 2 rate <80 for 6 h, a decision was made to implement VV ECMO. Both patients were discharged from the intensive care unit (Case 1: on day 35; Case 2: on day 22). Rapid implementation of VV ECMO in middle-aged, obese patients with ARDS in the course of COVID-19 showed a positive outcome.

Suggested Citation

  • Jarosław Janc & Lidia Łysenko & Olga Lewandowska & Olimpia Chrzan & Michał Suchański & Marek Gemel & Patrycja Leśnik, 2022. "A Successful Outcome of Veno-Venous Extracorporeal Membrane Oxygenation in Obese Patients with Respiratory Failure in the Course of COVID-19: A Report of Two Cases," IJERPH, MDPI, vol. 19(5), pages 1-9, February.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:5:p:2761-:d:759927
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/5/2761/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/5/2761/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Brandi N. Williamson & Friederike Feldmann & Benjamin Schwarz & Kimberly Meade-White & Danielle P. Porter & Jonathan Schulz & Neeltje Doremalen & Ian Leighton & Claude Kwe Yinda & Lizzette Pérez-Pérez, 2020. "Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2," Nature, Nature, vol. 585(7824), pages 273-276, September.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Alejandro Piscoya & Luis F Ng-Sueng & Angela Parra del Riego & Renato Cerna-Viacava & Vinay Pasupuleti & Yuani M Roman & Priyaleela Thota & C Michael White & Adrian V Hernandez, 2020. "Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis," PLOS ONE, Public Library of Science, vol. 15(12), pages 1-19, December.
    2. Yongsheng Huang & Xiaoyu Lyu & Dan Li & Lin Wang & Yujun Wang & Wenbin Zou & Yingxin Wei & Xiaowei Wu, 2020. "A cohort study of 676 patients indicates D-dimer is a critical risk factor for the mortality of COVID-19," PLOS ONE, Public Library of Science, vol. 15(11), pages 1-11, November.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:5:p:2761-:d:759927. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.